Compounds > atazanavir sulfate
Page last updated: 2024-09-04

atazanavir sulfate and baricitinib

atazanavir sulfate has been researched along with baricitinib in 1 studies

Compound Research Comparison

Studies
(atazanavir sulfate)		Trials
(atazanavir sulfate)		Recent Studies (post-2010)
(atazanavir sulfate)		Studies
(baricitinib)		Trials
(baricitinib)		Recent Studies (post-2010) (baricitinib)
1,10224659065395631

Protein Interaction Comparison

ProteinTaxonomyatazanavir sulfate (IC50)baricitinib (IC50)
Cyclin-G-associated kinaseHomo sapiens (human)0.136
Tyrosine-protein kinase JAK2Homo sapiens (human)0.1233
Tyrosine-protein kinase JAK1Homo sapiens (human)0.0739
Non-receptor tyrosine-protein kinase TYK2Homo sapiens (human)0.1565
Tyrosine-protein kinase JAK3Homo sapiens (human)0.4477
AP2-associated protein kinase 1Homo sapiens (human)0.017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Eugênio, E; Livinalli, A; Moraes, EL; Negrete, CL; Paes, RD; Serpa Osorio-de-Castro, CG; Sobreira da Silva, MJ1

Other Studies

1 other study(ies) available for atazanavir sulfate and baricitinib

ArticleYear
Potential interactions between antineoplastic agents and medicines used to treat Covid-19.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:8

    Topics: Antineoplastic Agents; Antiviral Agents; Atazanavir Sulfate; COVID-19 Drug Treatment; Drug Combinations; Drug Interactions; Humans; Lopinavir; Ritonavir

2022